Steven A. Gould

Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL.

Helus, Inc. offers secure communication, content exchange, electronic commerce and clinical workflow for community-based physician practices. The company is headquartered in Chicago, IL.

Abundant Venture Partners LLC (Abundant Venture Partners) is a venture capital firm founded in 2011 by Andrew Swinand and Eric Langshur. The firm is headquartered in Chicago, Illinois.

The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage.